Participants are being recruited to participate in a research study to test the safety, tolerability and effectiveness of Immune Globulin Intravenous (IGIV) therapy to treat Multifocal Motor Neuropathy. Participants must be on a stable dose of IGIV for at least 3 months prior to enrollment.
For more information, please contact Amy Bartlett at (614) 366-9050 or by e-mail at
amy.bartlett@osumc.edu.